Dcf Advisers 13F annual report
Dcf Advisers is an investment fund managing more than $163 billion ran by David Floren. There are currently 67 companies in Mr. Floren’s portfolio. The largest investments include Micron Technology and Alphabet Inc, together worth $29.7 billion.
$163 billion Assets Under Management (AUM)
As of 8th May 2024, Dcf Advisers’s top holding is 159,500 shares of Micron Technology currently worth over $18.8 billion and making up 11.6% of the portfolio value.
Relative to the number of outstanding shares of Micron Technology, Dcf Advisers owns more than approximately 0.1% of the company.
In addition, the fund holds 71,650 shares of Alphabet Inc worth $10.9 billion, whose value grew 26.1% in the past six months.
The third-largest holding is Regeneron Pharmaceuticals worth $10.2 billion and the next is Argenx Se worth $7.95 billion, with 20,200 shares owned.
Currently, Dcf Advisers's portfolio is worth at least $163 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Dcf Advisers
The Dcf Advisers office and employees reside in Greenwich, Connecticut. According to the last 13-F report filed with the SEC, David Floren serves as the Managing Member at Dcf Advisers.
Recent trades
In the most recent 13F filing, Dcf Advisers revealed that it had opened a new position in
Baidu Inc and bought 19,250 shares worth $2.03 billion.
This means they effectively own approximately 0.1% of the company.
Baidu Inc makes up
4.2%
of the fund's Technology sector allocation and has decreased its share price by 14.3% in the past year.
The investment fund also strengthened its position in Alphabet Inc by buying
1,500 additional shares.
This makes their stake in Alphabet Inc total 71,650 shares worth $10.9 billion.
Alphabet Inc soared 47.0% in the past year.
On the other hand, there are companies that Dcf Advisers is getting rid of from its portfolio.
Dcf Advisers closed its position in Seagen Inc on 15th May 2024.
It sold the previously owned 11,000 shares for $2.33 billion.
David Floren also disclosed a decreased stake in Micron Technology by approximately 0.1%.
This leaves the value of the investment at $18.8 billion and 159,500 shares.
One of the smallest hedge funds
The two most similar investment funds to Dcf Advisers are Friedenthal and Worth Asset Management. They manage $163 billion and $163 billion respectively.
David Floren investment strategy
Dcf Advisers’s portfolio is diversified across 9 sectors.
Currently, their heaviest sector is Technology — making up 29.9% of
the total portfolio value.
The fund focuses on investments in the United States as
44.8% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
37% of the total holdings value.
On the other hand, small-cap stocks make up only 3.0% of the portfolio.
The average market cap of the portfolio companies is close to $170 billion.
The complete list of Dcf Advisers trades based on 13F SEC filings
These positions were updated on May 15th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
Security | Shares Owned | Value | Allocation |
---|---|---|---|
Micron Technology Inc. |
2.15%
159,500
|
$18,803,455,000 | 11.57% |
Alphabet Inc |
2.14%
71,650
|
$10,909,429,000 | 6.71% |
Regeneron Pharmaceuticals, Inc. |
2.53%
10,600
|
$10,202,394,000 | 6.28% |
Argenx Se |
8.18%
20,200
|
$7,953,144,000 | 4.89% |
Advanced Micro Devices Inc. |
6.63%
38,000
|
$6,858,620,000 | 4.22% |
Intra-Cellular Therapies Inc |
9.61%
96,857
|
$6,702,504,000 | 4.12% |
Abbvie Inc |
28.54%
31,800
|
$5,790,780,000 | 3.56% |
Lilly Eli & Co |
6.67%
7,000
|
$5,445,720,000 | 3.35% |
Oracle Corp. |
4.12%
40,750
|
$5,118,608,000 | 3.15% |
Energy Transfer L P |
17.09%
309,250
|
$4,864,503,000 | 2.99% |
Bank America Corp |
3.20%
125,350
|
$4,753,272,000 | 2.92% |
Xencor Inc |
15.15%
208,979
|
$4,624,705,000 | 2.85% |
Spdr Gold Tr |
2.33%
22,000
|
$4,525,840,000 | 2.78% |
Ishares Gold Tr |
No change
100,000
|
$4,201,000,000 | 2.58% |
Incyte Corp. |
15.73%
51,500
|
$2,933,955,000 | 1.81% |
AMGEN Inc. |
22.62%
10,300
|
$2,928,496,000 | 1.80% |
Zimmer Biomet Holdings Inc |
18.06%
21,719
|
$2,866,474,000 | 1.76% |
Alibaba Group Hldg Ltd |
79.81%
38,300
|
$2,771,388,000 | 1.71% |
Prothena Corp Plc |
28.99%
107,000
|
$2,650,390,000 | 1.63% |
Apple Inc |
No change
14,750
|
$2,529,330,000 | 1.56% |
Turning Pt Brands Inc |
No change
83,500
|
$2,446,550,000 | 1.51% |
Ishares Tr |
No change
24,000
|
$2,931,950,000 | 1.80% |
Seagen Inc |
Closed
11,000
|
$2,333,650,000 | |
Nuveen Cr Strategies Income |
1.19%
415,000
|
$2,311,550,000 | 1.42% |
Aberdeen Total Dynamic Divd |
3.16%
261,500
|
$2,167,835,000 | 1.33% |
Baidu Inc |
Opened
19,250
|
$2,026,640,000 | 1.25% |
General Mtrs Co |
20.45%
35,000
|
$1,587,250,000 | 0.98% |
Lifecore Biomedical Inc |
135.76%
284,684
|
$1,511,672,000 | 0.93% |
VanEck ETF Trust |
1.16%
61,200
|
$2,032,688,000 | 1.25% |
Cisco Sys Inc |
33.33%
30,000
|
$1,497,300,000 | 0.92% |
Qualcom Inc |
No change
8,500
|
$1,439,050,000 | 0.89% |
O-I Glass Inc |
44.73%
85,750
|
$1,422,593,000 | 0.88% |
Ford Mtr Co Del |
No change
100,000
|
$1,328,000,000 | 0.82% |
Revance Therapeutics Inc |
893.86%
263,372
|
$1,295,790,000 | 0.80% |
Marvell Technology Inc |
No change
17,500
|
$1,240,400,000 | 0.76% |
Barrick Gold Corp. |
38.10%
72,500
|
$1,206,400,000 | 0.74% |
Teva Pharmaceutical Inds Ltd |
91.01%
85,000
|
$1,199,350,000 | 0.74% |
AT&T, Inc. |
54.39%
65,000
|
$1,144,000,000 | 0.70% |
Ishares Silver Tr |
No change
50,000
|
$1,137,500,000 | 0.70% |
EA Series Trust |
31.67%
9,875
|
$1,051,293,000 | 0.65% |
Spdr Ser Tr |
Closed
13,500
|
$985,770,000 | |
Altimmune Inc |
19.80%
96,225
|
$979,571,000 | 0.60% |
Meta Platforms Inc |
No change
2,000
|
$971,160,000 | 0.60% |
Srh Total Return Fund Inc |
No change
59,000
|
$888,540,000 | 0.55% |
Burford Cap Ltd |
6.78%
55,000
|
$878,350,000 | 0.54% |
Boeing Co. |
120.00%
4,400
|
$849,156,000 | 0.52% |
Intel Corp. |
20.21%
18,750
|
$828,188,000 | 0.51% |
Lensar Inc |
15.68%
238,234
|
$809,281,000 | 0.50% |
Teladoc Health Inc |
Opened
51,400
|
$776,140,000 | 0.48% |
Paypal Hldngs Inc |
18.52%
11,000
|
$736,890,000 | 0.45% |
Pan Amern Silver Corp |
No change
45,000
|
$678,600,000 | 0.42% |
Amazon.com Inc. |
Closed
5,000
|
$635,600,000 | |
Wolfspeed Inc |
47.14%
20,600
|
$607,700,000 | 0.37% |
Sanofi |
11.11%
11,000
|
$534,600,000 | 0.33% |
Pfizer Inc. |
50.00%
19,250
|
$534,188,000 | 0.33% |
Spotify Technology S.A. |
No change
2,000
|
$527,800,000 | 0.32% |
Lam Research Corp. |
No change
500
|
$485,785,000 | 0.30% |
YETI Holdings Inc |
Opened
12,500
|
$481,875,000 | 0.30% |
Citigroup Inc |
No change
7,250
|
$458,490,000 | 0.28% |
Samsara Inc. |
Opened
10,000
|
$377,900,000 | 0.23% |
Evotec Ag |
2.55%
47,797
|
$374,251,000 | 0.23% |
Alnylam Pharmaceuticals Inc |
Closed
1,800
|
$318,780,000 | |
Bristol-Myers Squibb Co. |
Closed
5,250
|
$304,710,000 | |
Palo Alto Networks Inc |
Opened
1,000
|
$284,130,000 | 0.17% |
Viridian Therapeutics Inc |
7.41%
14,500
|
$253,895,000 | 0.16% |
Johnson & Johnson |
No change
1,500
|
$237,285,000 | 0.15% |
Air T, Inc. |
Closed
9,135
|
$204,167,000 | |
Immunogen, Inc. |
Closed
12,850
|
$203,930,000 | |
Nokia Corp |
70.85%
50,000
|
$177,000,000 | 0.11% |
Paramount Global |
Closed
12,500
|
$161,250,000 | |
Lineage Cell Therapeutics In |
30.21%
107,751
|
$159,471,000 | 0.10% |
Arq Inc |
Opened
16,000
|
$103,680,000 | 0.06% |
Vir Biotechnology Inc |
Closed
10,000
|
$93,700,000 | |
Impel Pharmaceuticals Inc |
Closed
178,500
|
$76,755,000 | |
Kirklands Inc |
27.87%
25,415
|
$61,250,000 | 0.04% |
Ovid Therapeutics Inc |
35.16%
19,730
|
$60,177,000 | 0.04% |
Equillium Inc |
Closed
69,871
|
$51,705,000 | |
Amarin Corp Plc |
5.74%
13,290
|
$11,839,000 | 0.01% |
No transactions found | |||
Showing first 500 out of 78 holdings |